Senior insider sale
Chief Scientific Officer at ENTRADA THERAPEUTICS, INC. — senior position signals high conviction
$510.2K
37.38K shares
What this filing means
SETHURAMAN NATARAJAN plans to sell 37.38K shares of ENTRADA THERAPEUTICS, INC. valued at approximately $510.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/4/2026ACC: 0001950047-26-004000
Officer· Chief Scientific Officer
Since Oct 2021
37.38K
Shares to sell
$510.2K
Approx. market value
25.91K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
3/1/2025
25.91KTotal acquired25.91K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted Stock Units N/A | 25.91K | — |
| Total | 25.91K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.58K
Market value
$89.1K
3/3/2026
—Completed
Units to sell
3.90K
Market value
$45.4K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
25.91K
Market value
$375.7K
5/4/2026
Total
Units
37.38K
Value
$510.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/3/2026 | 7.58K | $89.1K | — | Completed |
3/2/2026 | 3.90K | $45.4K | — | Completed |
| Planned — Approximate Date | ||||
5/4/2026 | 25.91K | $375.7K | NASDAQ | Planned |
| Total | 37.38K | $510.2K | ||